Plasma TechMed develops the EyeR medical device, which utilizes cold plasma technology for the disinfection of the eye, effectively targeting viruses, fungi, and bacteria. This device provides a rapid, painless treatment for infectious keratitis, promoting tissue regeneration and healing without significant side effects or interactions with other therapies.
Funding
$28.4K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Infectious keratitis, a corneal infection caused by viruses, fungi, or bacteria, can lead to significant vision impairment and even blindness if left untreated. Current treatments may have limited effectiveness, potential side effects, or interactions with other medications.
Solution
Plasma TechMed's EyeR device offers a rapid, painless solution for infectious keratitis using cold plasma technology to disinfect the eye. The device locally targets and eliminates viruses, fungi, and bacteria without interacting with other therapies or causing significant side effects. EyeR also promotes tissue regeneration and healing of the cornea, helping to restore vision and improve patient outcomes. The device's localized application and rapid treatment time make it a convenient and well-tolerated option for patients.
Target Audience
The primary target audience includes ophthalmologists and other medical professionals treating patients with infectious keratitis.
Features
- Cold plasma technology for disinfection of the eye
- Targets viruses, fungi, and bacteria
- Promotes tissue regeneration and healing
- Rapid treatment time
- Painless application
- No known contraindications
- No interactions with other medications
- No plasma-resistance